Lipid changes due to fenofibrate treatment are not associated with changes in DNA methylation patterns in the GOLDN study

Fenofibrate lowers triglycerides (TG) and raises high density lipoprotein cholesterol (HDLc) in dyslipidemic individuals. Several studies have shown genetic variability in lipid responses to fenofibrate treatment. It is, however, not known whether epigenetic patterns are also correlated with the cha...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Genet
Asıl Yazarlar: Das, Mithun, Irvin, M. Ryan, Sha, Jin, Aslibekyan, Stella, Hidalgo, Bertha, Perry, Rodney T., Zhi, Degui, Tiwari, Hemant K., Absher, Devin, Ordovas, Jose M., Arnett, Donna K.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2015
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4586504/
https://ncbi.nlm.nih.gov/pubmed/26483836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fgene.2015.00304
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller